ARTICLE | Company News
AvidBiotics splits in two
December 8, 2017 4:21 AM UTC
In November, AvidBiotics Corp (South San Francisco, Calif.) said it will split into two separate entities. One company, Xyphos Inc., will develop its chimeric antigen receptor (CAR) T cell platform, convertibleCAR, for immuno-oncology applications. The other, microbiome-focused Pylum Biosciences Inc., will seek to develop antibacterial proteins for microbiota management and drug-resistant bacteria using its Avidocin technology. Both companies will be located initially in South San Francisco, Calif...
BCIQ Company Profiles